- Access to CME/CE programs and certification
- Additional information from the provider
- Reminders of new CME/CE activities and related content
Genentech, Inc.
Biogen Idec
Amgen
Wyeth
UCB
Our searchable bibliography is a comprehensive listing of articles, posters, abstracts, and CME programs on biologic therapy in rheumatoid arthritis. Links to these documents are provided where possible.
| 170 Total Entries |  Printer-friendly version |
Lovell DJ‚ Ruperto N‚ Goodman S‚ et al. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med. 2008; 359(8):810-20.
Date Published: August 2008
Keywords:
View Abstract
Allaire S‚ Wolfe F‚ Niu J‚ et al. Evaluation of the effect of anti-tumor necrosis factor agent use on rheumatoid arthritis work disability: the jury is still out. Arthritis Rheum. 2008; 59(8):1082-9.
Date Published: August 2008
Keywords:
View Abstract
Li LC‚ Badley EM‚ MacKay C‚ et al. An evidence-informed’ integrated framework for rheumatoid arthritis care. Arthritis Rheum. 2008; 59(8):1171-83.
Date Published: August 2008
Keywords:
View Abstract
Nadareishvili Z‚ Michaud K‚ Hallenbeck JM‚ et al. Cardiovascular’ rheumatologic’ and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested’ case-control study. Arthritis Rheum. 2008; 59(8):1090-6.
Date Published: August 2008
Keywords:
View Abstract
Emery P‚ Breedveld FC‚ Hall S‚ et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active’ early’ moderate to severe rheumatoid arthritis (COMET): a randomised’ double-blind’ parallel treatment trial. Lancet. 2008; 372(9636):375-82.
Date Published: August 2008
Keywords:
View Abstract
Kremer JM. COMET’s path’ and the new biologicals in rheumatoid arthritis. Lancet. 2008; 372(9636):347-8.
Date Published: August 2008
Keywords:
View Abstract
Ruperto N‚ Lovell DJ‚ Quartier P‚ et al. Abatacept in children with juvenile idiopathic arthritis: a randomised’ double-blind’ placebo-controlled withdrawal trial. Lancet. 2008; 372(9636):383-91.
Date Published: August 2008
Keywords:
View Abstract
Doggrell SA. Is tocilizumab an option for the treatment of arthritis? Expert Opin Pharmacother. 2008; 9(11):2009-13.
Date Published: August 2008
Keywords:
View Abstract
Genant HK‚ Peterfy CG‚ Westhovens R‚ et al. Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial. Ann Rheum Dis. 2008; 67(8):1084-9.
Date Published: August 2008
Keywords:
View Abstract
Gerloni V‚ Pontikaki I‚ Gattinara M‚ et al . Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients. Ann Rheum Dis. 2008; 67(8):1145-52.
Date Published: August 2008
Keywords:
View Abstract
Hutas G. Golimumab’ a fully human monoclonal antibody against TNFalpha. Curr Opin Mol Ther. 2008; 10(4):393-406.
Date Published: August 2008
Keywords:
View Abstract
Kremers HM‚ Crowson CS‚ Therneau TM‚ et al. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum. 2008; 58(8):2268-74.
Date Published: August 2008
Keywords:
View Abstract
Saleem B‚ Mackie S‚ Quinn M‚ et al. Does the use of tumour necrosis factor antagonist therapy in poor prognosis’ undifferentiated arthritis prevent progression to rheumatoid arthritis? Ann Rheum Dis. 2008; 67(8):1178-80.
Date Published: August 2008
Keywords:
View Abstract
Schiff M‚ Keiserman M‚ Codding C‚ et al. Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III’ multi-centre’ randomised’ double-blind’ placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate. Ann Rheum Dis. 2008; 67(8):1096-103.
Date Published: August 2008
Keywords:
View Abstract
Sebba A. Tocilizumab: the first interleukin-6-receptor inhibitor. Am J Health Syst Pharm. 2008; 65(15):1413-8.
Date Published: August 2008
Keywords:
View Abstract
Setoguchi S‚ Schneeweiss S‚ Avorn J‚ et al. Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis. Am Heart J. 2008; 156(2):336-41.
Date Published: August 2008
Keywords:
View Abstract
Sizova L. Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs. Br J Clin Pharmacol. 2008; 66(2):173-8.
Date Published: August 2008
Keywords:
View Abstract
Tanaka E‚ Mannalithara A‚ Inoue E‚ et al. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability. Ann Rheum Dis. 2008; 67(8):1153-8.
Date Published: August 2008
Keywords:
View Abstract
van Riel PL‚ Freundlich B‚ MacPeek D‚ et al. Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial. Ann Rheum Dis. 2008; 67(8):1104-10.
Date Published: August 2008
Keywords:
View Abstract
Wijbrandts CA‚ Dijkgraaf MG‚ Kraan MC‚ et al. The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium. Ann Rheum Dis. 2008; 67(8):1139-44.
Date Published: August 2008
Keywords:
View Abstract
Haynes D‚ Crotti T‚ Weedon H‚ et al. Modulation of RANKL and osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis in response to disease-modifying antirheumatic drug treatment and correlation with radiologic outcome. Arthritis Rheum. 2008; 59(7):911-20.
Date Published: July 2008
Keywords:
View Abstract
Grijalva CG‚ Chung CP‚ Stein CM‚ et al. Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population. Rheumatology (Oxford). 2008; 47(7):1061-4.
Date Published: July 2008
Keywords:
View Abstract
Hyrich KL‚ Lunt M‚ Dixon WG‚ et al. Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug Rheumatology (Oxford). 2008; 47(7):1000-5.
Date Published: July 2008
Keywords:
View Abstract
Bathon JM‚ Cohen SB. The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: where the rubber meets the road. Arthritis Rheum. 2008; 59(6): 757-9.
Date Published: June 2008
Keywords:
View Abstract
Saag KG‚ Teng GG‚ Patkar NM‚ et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008; 59(6): 762-84.
Date Published: June 2008
Keywords:
View Abstract